Impact of Fever Prevention in Brain-Injured Patients (INTREPID): Study Protocol for a Randomized Controlled Trial.

Greer, David M; Ritter, Jaime; Helbok, Raimund; Badjatia, Neeraj; Ko, Sang-Bae; Guanci, Mary; Sheth, Kevin N

Greer, David M; Ritter, Jaime; Helbok, Raimund; Badjatia, Neeraj; Ko, Sang-Bae; Guanci, Mary; Sheth, Kevin N.

Affiliation

Greer DM; Department of Neurology, Boston University School of Medicine, Boston Medical Center, Collamore 3, Suite 338, 72 East Concord Street, Boston, MA, USA. dgreer@bu.edu.
Ritter J; Becton Dickenson & Company, Franklin Lakes, NJ, USA.
Helbok R; Department of Neurology, Neurology Medical University of Innsbruck, Anichstreet 65, 6020, Innsbruck, Austria.
Badjatia N; Program in Trauma, Department of Neurology, University of Maryland School of Medicine, 655 West Baltimore Street, Baltimore, MD, USA.
Ko SB; Department of Neurology, Boston University School of Medicine, Boston Medical Center, Collamore 3, Suite 338, 72 East Concord Street, Boston, MA, USA.
Guanci M; Neurocritical Care Unit, Massachusetts General Hospital, Lunder Building 6th Floor, 55 Fruit Street, Boston, MA, USA.
Sheth KN; Department of Neurology, Yale University School of Medicine, 15 York Street, LCI 1003, New Haven, CT, USA.

Neurocrit Care ; 35(2): 577-589, 2021 10.

Article in En | MEDLINE | ID: mdl-33761119

Subject(s)

COVID-19; Brain; Critical Care; Humans; Prospective Studies; Randomized Controlled Trials as Topic; SARS-CoV-2

Key words

Fever; Intracerebral hemorrhage; Ischemic stroke; Normothermia; Prevention; Subarachnoid hemorrhage

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Type of study: Clinical_trials / Guideline / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Neurocrit Care Journal subject: NEUROLOGIA / TERAPIA INTENSIVA Year: 2021 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google